These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32488475)

  • 1. Anti-GM-CSF Autoantibodies and Cryptococcus neoformans var. grubii CNS Vasculitis.
    Perrineau S; Guery R; Monnier D; Puel A; Lanternier F
    J Clin Immunol; 2020 Jul; 40(5):767-769. PubMed ID: 32488475
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.
    Saijo T; Chen J; Chen SC; Rosen LB; Yi J; Sorrell TC; Bennett JE; Holland SM; Browne SK; Kwon-Chung KJ
    mBio; 2014 Mar; 5(2):e00912-14. PubMed ID: 24643864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated Cryptococcosis Due to Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Absence of Pulmonary Alveolar Proteinosis.
    Kuo CY; Wang SY; Shih HP; Tu KH; Huang WC; Ding JY; Lin CH; Yeh CF; Ho MW; Chang SC; He CY; Chen HK; Ho CH; Lee CH; Chi CY; Ku CL
    J Clin Immunol; 2017 Feb; 37(2):143-152. PubMed ID: 28013480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies Neutralizing GM-CSF in HIV-Negative Colombian Patients Infected with Cryptococcus gattii and C. neoformans.
    Arango-Franco CA; Rojas J; Firacative C; Migaud M; Agudelo CI; Franco JL; Casanova JL; Puel A; Lizarazo J; Castañeda E; Arias AA
    J Clin Immunol; 2024 Jul; 44(7):163. PubMed ID: 39008214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptococcus gattii Infection as the Major Clinical Manifestation in Patients with Autoantibodies Against Granulocyte-Macrophage Colony-Stimulating Factor.
    Wang SY; Lo YF; Shih HP; Ho MW; Yeh CF; Peng JJ; Ting HT; Lin KH; Huang WC; Chen YC; Chiu YH; Hsu CW; Tseng YT; Wang LS; Lei WY; Lin CY; Aoh Y; Chou CH; Wu TY; Ding JY; Lo CC; Lin YN; Tu KH; Lei WT; Kuo CY; Chi CY; Ku CL
    J Clin Immunol; 2022 Nov; 42(8):1730-1741. PubMed ID: 35947322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-GM-CSF Neutralizing Autoantibodies in Colombian Patients with Disseminated Cryptococcosis.
    Arango-Franco CA; Migaud M; Ramírez-Sánchez IC; Arango-Bustamante K; Moncada-Vélez M; Rojas J; Gervais A; Patiño-Giraldo S; Perez-Zapata LJ; Álvarez Álvarez JA; Orrego JC; Roncancio-Villamil G; Boisson-Dupuis S; Jouanguy E; Abel L; Casanova JL; Bustamante J; Arias AA; Franco JL; Puel A
    J Clin Immunol; 2023 Jul; 43(5):921-932. PubMed ID: 36821021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Patients With Central Nervous System and Localized Cryptococcosis: Longitudinal Follow-up and Literature Review.
    Kuo PH; Wu UI; Pan YH; Wang JT; Wang YC; Sun HY; Sheng WH; Chen YC; Chang SC
    Clin Infect Dis; 2022 Aug; 75(2):278-287. PubMed ID: 34718451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of Cryptococcus Meningoencephalitis].
    Miyazato A
    Med Mycol J; 2016; 57(1):J27-32. PubMed ID: 26936349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of anti-granulocyte-macrophage colony-stimulating factor antibodies in cryptococcal infection: case series and review of antibody testing.
    Stevenson B; Bundell C; Mulrennan S; McLean-Tooke A; Murray R; Brusch A
    Intern Med J; 2019 Nov; 49(11):1446-1450. PubMed ID: 31713345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pathogenic Role of Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Nocardiosis with the Central Nervous System Involvement.
    Lo YF; Wang SY; Wu YH; Ho MW; Yeh CF; Wu TY; Peng JJ; Lin YN; Ding JY; Shih HP; Lo CC; Chan YP; Rau CS; Kuo CY; Tu KH; Lei WT; Chen YC; Ku CL
    J Clin Immunol; 2024 Aug; 44(8):176. PubMed ID: 39133333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-GM-CSF autoantibodies predict outcome of cryptococcal meningitis in patients not infected with HIV: A cohort study.
    Jiang YK; Zhou LH; Cheng JH; Zhu JH; Luo Y; Li L; Zhu M; Zhu RS; Qiu WJ; Zhao HZ; Wang X; Huang JT; Cornely OA; Zhang WH; Zhu LP
    Clin Microbiol Infect; 2024 May; 30(5):660-665. PubMed ID: 38295989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated cryptococcosis and anti-granulocyte-macrophage colony-stimulating factor autoantibodies: An underappreciated association.
    Viola GM; Malek AE; Rosen LB; DiNardo AR; Nishiguchi T; Okhuysen PC; Holland SM; Kontoyiannis DP
    Mycoses; 2021 Jun; 64(6):576-582. PubMed ID: 33476401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis.
    Chen GH; Olszewski MA; McDonald RA; Wells JC; Paine R; Huffnagle GB; Toews GB
    Am J Pathol; 2007 Mar; 170(3):1028-40. PubMed ID: 17322386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies neutralizing GM-CSF in HIV-negative Colombian patients infected with Cryptococcus gattii and C. neoformans.
    Arango-Franco CA; Rojas J; Firacative C; Agudelo CI; Franco JL; Casanova JL; Puel A; Lizarazo J; Castañeda E; Arias AA
    Res Sq; 2024 Jan; ():. PubMed ID: 38313298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual Presentation of Severe Endobronchial Obstruction Caused by Cryptococcus gattii in a Child.
    Huynh J; Saddi V; Cooper P; Cheng AT; Meyer W; Chen S; Isaacs D
    J Pediatric Infect Dis Soc; 2020 Feb; 9(1):67-70. PubMed ID: 30339241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated/extrapulmonary nocardiosis.
    Rosen LB; Rocha Pereira N; Figueiredo C; Fiske LC; Ressner RA; Hong JC; Gregg KS; Henry TL; Pak KJ; Baumgarten KL; Seoane L; Garcia-Diaz J; Olivier KN; Zelazny AM; Holland SM; Browne SK
    Clin Infect Dis; 2015 Apr; 60(7):1017-25. PubMed ID: 25472947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcus neoformans var. neoformans (serotype D) strains are more susceptible to heat than C. neoformans var. grubii (serotype A) strains.
    Martinez LR; Garcia-Rivera J; Casadevall A
    J Clin Microbiol; 2001 Sep; 39(9):3365-7. PubMed ID: 11526180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: Invasive Cryptococcosis in French Guiana: Immune and Genetic Investigation in Six Non-HIV Patients.
    Goupil de Bouillé J; Epelboin L; Henaff F; Migaud M; Abboud P; Blanchet D; Aznar C; Djossou F; Lortholary O; Elenga N; Puel A; Lanternier F; Demar M
    Front Immunol; 2022; 13():881352. PubMed ID: 35558066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans.
    Collins HL; Bancroft GJ
    Eur J Immunol; 1992 Jun; 22(6):1447-54. PubMed ID: 1601035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.
    Chen GH; Curtis JL; Mody CH; Christensen PJ; Armstrong LR; Toews GB
    J Immunol; 1994 Jan; 152(2):724-34. PubMed ID: 8283047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.